6:32AM Bioscrip Enters into agreement to acquire HomeChoice Partners for $70 mln in cash (BIOS) 10.71 : HomeChoice is a majority-owned subsidiary of DaVita HealthCare Partners (DVA). The purchase price is subject to adjustment pursuant to the terms of the agreement including potential additional consideration based on the results of operations. BioScrip also expects to realize the value of a future tax benefit estimated at $3.9 mln as a result of the transaction. HomeChoice is expected to generate ~ $70 mln in annual revenue. Once fully integrated, this business should generate Adjusted EBITDA margins between 12% and 14%.
Market Data 
Markets 
AI
